The Efficacy and Safety of Shoulder Chuna on in Patients with Shoulder Pain Caused by Traffic Accidents

Launched by JASENG MEDICAL FOUNDATION · Oct 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of a treatment called Chuna therapy for people suffering from shoulder pain caused by traffic accidents. Chuna is a type of therapy used in Korean medicine that aims to help improve movement and reduce pain. The trial is looking for participants aged 19 to 69 who have experienced shoulder pain and limited movement within five days of a traffic accident and are currently hospitalized because of it.

If you or a family member are considering participating, you will need to be able to communicate that you understand the study and provide consent. However, there are certain conditions that would exclude someone from joining, such as having serious diseases that cause shoulder pain or recent surgeries. If eligible, participants can expect to receive Chuna therapy along with care from healthcare professionals to monitor their progress. This trial is currently recruiting participants, and it's a great opportunity to explore a potential new approach to managing shoulder pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 19-69 years on the date they sign the consent form.
• • Patients with shoulder pain and restricted movement occurring within 5 days after a traffic accident.
• • Patients who are hospitalized due to traffic accident.
• • Patients with NRS of shoulder pain ≥ 5 with restricted movement due to a traffic accident.
• • Patients who provide consent to participate in the trial and return the informed consent form.
• Exclusion Criteria:
• • Patients with a specific serious disease that may cause shoulder pain: malignancy, spondylitis, inflammatory spondylitis, etc.
• • Patients with progressive neurological deficits or with severe neurological symptoms.
• • Patients with medical history of cervical surgery or shoulder surgery within the last three weeks.
• • Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
• • Chuna therapy is deemed inappropriate or unsafe due to conditions like fractures, dislocations, ligament tears, or unstable healing fractures; skeletal demineralization and ligament laxity with subluxation or dislocation; or inflammation
• • Presence of other chronic diseases that could interfere with treatment outcomes or interpretation, such as cardiovascular disease, kidney disease, diabetic neuropathy, dementia, or epilepsy
• • Currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study results
• • Acupuncture is deemed inappropriate or unsafe, such as in patients with bleeding disorders, those on anticoagulant therapy, those with severe diabetes prone to infection, or those with severe cardiovascular disease
• • Patients who are pregnant or planning to become pregnant.
• • Patients who are presence of severe mental illness
• • Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
• • Patients who are difficult to complete the research participation agreement.
• • Other patients whose participation in the trial is judged by a researcher to be problematic.